| Trial Identifier: | D6340C00001 |
| Sponsor: | AstraZeneca |
| Collaborator: | Covance, Inc MMS Holdings, Inc Catalent Pharma Solutions Takeda Pharmaceutical Company Ltd |
| NCTID: | NCT03272165 |
| Start Date: | October 2017 |
| Primary Completion Date: | March 2021 |
| Study Completion Date: | March 2021 |
| Condition: | Neurological & Brain - Other |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| English Version |
| Country | Location |
|---|---|
| US, TX | Dallas, TX, US, 75247 |
| US, WI | Madison, WI, US, 53704 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2023 Pharma Intelligence UK Limited (Citeline), a Norstella company